Format

Send to

Choose Destination
Transplant Proc. 2015 Jan-Feb;47(1):27-9. doi: 10.1016/j.transproceed.2014.12.008.

Kidney transplantation with organs from donors after circulatory death type 3: a prospective multicentric Spanish study (GEODAS 3).

Author information

1
Nephrology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain. Electronic address: josem.portoles@salud.madrid.org.
2
Nephrology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
3
Nephrology Department, Hospital del Mar, Parc de salut Mar, Barcelona, Spain.
4
Nephrology Department, Hospital Universitario de A Coruña, A Coruña, Spain.
5
Nephrology Department, Complejo H. Universitario de Albacete, Albacete, Spain.
6
Nephrology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
7
Nephrology Department, Hospital Universitario Cruces, Bilbao, Spain.
8
Nephrology Department, Fundación Jimenez Díaz, Madrid, Spain.

Abstract

To increase the number of kidney donors, new strategies are needed such as living donor programs, expanded criteria donors, or donors after circulatory death (DCD) kidney transplantation programs. The GEODAS group has started an observational, prospective, multicenter clinical study, collecting data from all DCD type-3 kidney transplantations performed in seven Spanish hospitals from January 2012 to January 2014. The preliminary results have shown a delayed graft function of 40.4% and graft survival of 93.7% with a nadir creatinine of 1.3 mg/dL. From all 33 potential donors included in the study, 32 were effective and 63 kidney grafts were transplanted with a utilization rate of 98.5%. Creatinine evolution (median [range]) was in the first month: 2.1 [0.6-5.6]; third month: 1.6 [0.8, 4.2]; first year: 1.6 [0.9-2.2]. These results are similar to kidney transplantation from donors after brain death as shown in the literature, especially in the graft and recipient survival rates. In addition, the controlled programs are easier and less expensive than uncontrolled DCD programs with a higher rate of graft use.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center